Longdom Conferences

Speaker

August 23, 2021    London, UK

6th Webinar on

Webinar on Crtical care and Emergency Medicine

Sanjay Agrawal

Sanjay Agrawal

Leading PHARMA CONSULTANT and INVENTOR India

Title: PROBIOTIC and COVID-19

Biography:

Sanjay Agrawal is a leading Independent Researcher, Pharmaceutical consultant and patent holder of more than 40 formulations..  He has actively worked in pharmaceutical and related industries for more than 35 years and started his firm Pharmaceutical Consultants and Inventor in 2005. Skilled in formulation development of Solid orals, liquids, multi-particulars, neutraceuticals and food products. Developed and commercialized novel, adaptable and patentable platform technologies for various dosage forms. Dr. Agrawal completed his post graduation in Biochemistry, Post Graduate Diploma in Yoga and Naturopathy from Global institute of Health & Management-Delhi, MBA in marketing from IMT.

He is Editor-in-Chief of renowned IJM Today and honorable member of the editorial board of The Antiseptic and QualPharma Magazine. He has published more than 100 papers in reputed national and international Publications. Dr Agrawal is meticulous, a keen observer and ultimate performer. Dr Sanjay Agrawal is also the illustrious member of the National Geographic Society and ex-member of scientific committee of IDMA. Dr Agrawal had received various awards for his valuable support and contributions in Healthcare and pharmaceutical sector. He has worked with  many International and national  Pharmaceuticals company at various positions. 

Dr Agrawal is founder of Pharmaceutical Consultants and Inventor.  The firm works with diverse base of companies across the globe. It support Food, Pharma and Neutraceutical industries by consulting in Regulatory work, providing unique molecules and helping firms in creating brand image. Dr Agrawal is associated with many colleges and institution and believes initiative in bridging the gap between academics and industry.

 

Useful Links

News

Recovery and Restitution of critical care Services during the COVID-19 pandemic policy statement

2021-03-04 - 2021-03

Pressure on UK ICUs due to the COVID-19 pandemic will continue for many months to come, even as the vaccine reduces transmission rates. A slow recovery phase from the winter 2020-21 wave of infections will be complex and dependent on CRITCON status, staffing support and other operational pressures. Sustained use of surge capacity is likely, and will impede recovery by impacting staffing and operational processes. This document provides a list of principles and recommendations for the recovery phase for ICUs. This document will cover 4 key areas: General Principles of a Critical Care Recovery Plan with a focus on: Space and services, Staffing, Specialist Equipment and impact on Scheduled Surgery. A description of the Critical Care recovery phases and definitions. The timeline for this will be unknown at this time but likely to be many months and potentially years (or at least a more significant increase in activity during Winter months than previous years). Criteria and recommendations for each of the described recovery phases. This is not exhaustive but meant as a toolkit to help support trusts transition ICUs back to occupancy relative to baseline of 80-100% whilst balancing the inevitable tensions of increasing productivity in other specialist areas such as planned surgery. Data showing the scale of additional ICU beds opened in January 2021 compared with January 2020. This is compared regionally. It is crucial when reviewing this data to understand that regions will have experienced peak demands at different times and therefore further analysis will be needed for bed capacity and workforce modelling in the future.

Newsletter

© 2024 All Rights Reserved by Longdom